Many people relax those habits at dawn, dusk, or on cloudy days. "People potentially get lulled into a sense of security when the intensity of sunlight is weak and they spend too long outdoors without adequate protection," Neale said. "We have shown that is a problem for skin damage."

What kind of damage did they see?

The team hunted for molecular changes that appear well before cancer develops. Among the markers:

• p53, a protein that rises when skin cells are under pressure or their DNA is damaged
• UV-induced DNA lesions, meaning direct breaks and chemical changes in the genetic code

The UV dose used in the study was deliberately too low to produce visible sunburn. Even so, both biomarkers shifted.

Does this mean small UV doses cause cancer right away?

No. Detectable DNA damage is not the same as cancer. Study co-lead Professor David Whiteman AM drew the line carefully: "Our lab results show these small, incremental doses of UV have caused some damage to the DNA in the skin cells, enough for the cells to then respond to the damage. Over months and years, these episodes of incremental, incidental UV exposure will have a cumulative impact on the skin and can lead to mutations that will initiate skin cancer."

Each low-dose outing leaves a small fingerprint of harm. Repeated often enough, those fingerprints add up.

What should people change?

The team does not call for sun avoidance. Sunlight drives vitamin D production and supports overall health. Instead, they want public guidance updated to reflect biological evidence rather than assumptions about intensity.

Their stated goal: "give Australians accurate, trustworthy guidance" about whether sunlight considered "safe" is truly risk-free at the cellular level.

They also recommend treating sunscreen as a daily habit, not a beach-day accessory. Short, unplanned exposures (walking the dog, hanging laundry, waiting at a bus stop) can quietly add to a person's lifetime UV tally.

How strong is the evidence?

The peer-reviewed paper appears in Photochemistry and Photobiology. The trial enrolled 58 participants with light to olive skin, a relatively small group that limits how broadly the results apply. The researchers measured molecular markers, not actual cancer outcomes, so the work maps early steps along a long causal chain.

Still, the design directly compared low- and high-intensity UV at matched total doses, an approach earlier observational studies could not isolate. That makes the dose-versus-intensity conclusion harder to dismiss.